title: Nodular amyloidosis of all four eyelids: first presenting symptom of Waldenström macroglobulinaemia.
authors.affiliation: Department of Ophthalmology, Naestved Sygehus, Naestved, DenmarkDepartment of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, DenmarkDepartment of Neuroscience and Pharmacology, Eye Pathology Institute, University of Copenhagen, Copenhagen, DenmarkDepartment of Oncology and Haematology, Naestved Sygehus, Naestved, Denmark.
authors.forename: Stine
authors.initials: S
authors.lastname: Jacoby
authors.forename: Peter B
authors.initials: PB
authors.lastname: Toft
authors.forename: Jan U
authors.initials: JU
authors.lastname: Prause
authors.forename: Preben
authors.initials: P
authors.lastname: Philip
authors.forename: Steffen
authors.initials: S
authors.lastname: Heegaard
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000175:diagnosis* / Q000188:drug therapy; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D017338:Cladribine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005141:Eyelid Diseases / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D017338:Cladribine; D000069283:Rituximab